Single-molecule FRET-based approach for protein-targeted drug discovery

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Type II topoisomerases are crucial targets for anticancer and antibacterial drugs.
• The precise action mechanisms of many drugs targeting these enzymes remain unclear.
• Efficient drug screening requires rapid and accurate methods to determine drug modes of action.

Purpose of the Study:

• To develop a single-molecule fluorescence resonance energy transfer (smFRET)-based method for screening drug candidates.
• To delineate the specific steps at which drugs interact with type II topoisomerases.
• To enhance the efficiency of drug discovery and development.

Main Methods:

• Utilized single-molecule fluorescence resonance energy transfer (smFRET) as the core technology.
• Employed type II topoisomerase as a model system for drug screening.
• Applied the method to analyze known type II topoisomerase inhibitors.

Main Results:

• Successfully demonstrated a novel smFRET-based drug screening method.
• Delineated the distinct mechanisms of action for etoposide and bisdioxopiperazines (ICRF-I93).
• Etoposide was shown to stabilize the enzyme-DNA cleavage complex, while ICRF-I93 locks the enzyme's N-terminal gate.

Conclusions:

• The developed smFRET method is effective for identifying drug mechanisms targeting type II topoisomerases.
• This approach significantly improves the efficiency of drug screening and discovery.
• The method holds potential for broad applications in screening drugs against various protein targets.